{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:27:05Z","timestamp":1736414825121,"version":"3.32.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-024-02441-w","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T03:57:40Z","timestamp":1736308660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Statistical methods in the analysis of multicentre HIV randomized controlled trials in the African region: a scoping review"],"prefix":"10.1186","volume":"25","author":[{"given":"Mikateko","family":"Mazinu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomonde","family":"Gwebushe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Manda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarylee","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"13","key":"2441_CR1","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/1471-0528.15199","volume":"125","author":"E Hariton","year":"2018","unstructured":"Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials. BJOG. 2018;125(13):1716.","journal-title":"BJOG"},{"issue":"1s","key":"2441_CR2","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.chest.2020.03.013","volume":"158","author":"EC Zabor","year":"2020","unstructured":"Zabor EC, Kaizer AM, Hobbs BP. Randomized Controlled Trials. Chest. 2020;158(1s):S79\u201387.","journal-title":"Chest"},{"issue":"7519","key":"2441_CR3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/bmj.331.7519.742","volume":"331","author":"N Siegfried","year":"2005","unstructured":"Siegfried N, Clarke M, Volmink J. Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ (Clinical Res ed). 2005;331(7519):742.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"4","key":"2441_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/jama.1992.03490040053025","volume":"268","author":"J Kreiss","year":"1992","unstructured":"Kreiss J, Ngugi E, Holmes K, Ndinya-Achola J, Waiyaki P, Roberts PL, Ruminjo I, Sajabi R, Kimata J, Fleming TR, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992;268(4):477\u201382.","journal-title":"JAMA"},{"issue":"10018","key":"2441_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(15)00984-8","volume":"387","author":"N Nagot","year":"2016","unstructured":"Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, et al. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet (London England). 2016;387(10018):566\u201373.","journal-title":"Lancet (London England)"},{"issue":"9583","key":"2441_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(07)60950-7","volume":"370","author":"NS Padian","year":"2007","unstructured":"Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (London England). 2007;370(9583):251\u201361.","journal-title":"Lancet (London England)"},{"issue":"1","key":"2441_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41077-017-0039-0","volume":"2","author":"A Cheng","year":"2017","unstructured":"Cheng A, Kessler D, Mackinnon R, Chang TP, Nadkarni VM, Hunt EA, Duval-Arnould J, Lin Y, Pusic M, Auerbach M. Conducting multicenter research in healthcare simulation: Lessons learned from the INSPIRE network. Adv Simul. 2017;2(1):6.","journal-title":"Adv Simul"},{"issue":"1","key":"2441_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12874-020-00971-7","volume":"20","author":"B Stuart","year":"2020","unstructured":"Stuart B, Becque T, Moore M, Little P. Clustering of continuous and binary outcomes at the general practice level in individually randomised studies in primary care - a review of 10 years of primary care trials. BMC Med Res Methodol. 2020;20(1):83.","journal-title":"BMC Med Res Methodol"},{"key":"2441_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41077-017-0039-0","volume":"2","author":"A Cheng","year":"2017","unstructured":"Cheng A, Kessler D, Mackinnon R, Chang TP, Nadkarni VM, Hunt EA, Duval-Arnould J, Lin Y, Pusic M, Auerbach M. Conducting multicenter research in healthcare simulation: Lessons learned from the INSPIRE network. Adv Simul (Lond). 2017;2:6.","journal-title":"Adv Simul (Lond)"},{"issue":"7483","key":"2441_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bmj.330.7483.142","volume":"330","author":"KJ Lee","year":"2005","unstructured":"Lee KJ, Thompson SG. Clustering by health professional in individually randomised trials. BMJ (Clinical Res ed). 2005;330(7483):142\u20134.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"1","key":"2441_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12874-015-0006-1","volume":"15","author":"H Oltean","year":"2015","unstructured":"Oltean H, Gagnier JJ. Use of clustering analysis in randomized controlled trials in orthopaedic surgery. BMC Med Res Methodol. 2015;15(1):17.","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"2441_CR12","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/sim.5667","volume":"32","author":"BC Kahan","year":"2013","unstructured":"Kahan BC, Morris TP. Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects? Stat Med. 2013;32(7):1136\u201349.","journal-title":"Stat Med"},{"issue":"1","key":"2441_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2288-14-20","volume":"14","author":"BC Kahan","year":"2014","unstructured":"Kahan BC. Accounting for centre-effects in multicentre trials with a binary outcome \u2013 when, why, and how? BMC Med Res Methodol. 2014;14(1):20.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"2441_CR14","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jclinepi.2015.03.016","volume":"68","author":"BC Kahan","year":"2015","unstructured":"Kahan BC, Harhay MO. Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs. J Clin Epidemiol. 2015;68(12):1504\u201311.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2441_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2288-13-58","volume":"13","author":"BC Kahan","year":"2013","unstructured":"Kahan BC, Morris TP. Assessing potential sources of clustering in individually randomised trials. BMC Med Res Methodol. 2013;13(1):58.","journal-title":"BMC Med Res Methodol"},{"issue":"15\u201316","key":"2441_CR16","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/(SICI)1097-0258(19980815\/30)17:15\/16<1779::AID-SIM979>3.0.CO;2-7","volume":"17","author":"AL Gould","year":"1998","unstructured":"Gould AL. Multi-centre trial analysis revisited. Stat Med. 1998;17(15\u201316):1779\u201397. discussion 1799\u20131800.","journal-title":"Stat Med"},{"issue":"1","key":"2441_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"4","key":"2441_CR18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.11124\/JBIES-21-00242","volume":"20","author":"MDJ Peters","year":"2022","unstructured":"Peters MDJ, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, Pollock D, Tricco AC, Munn Z. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953\u201368.","journal-title":"JBI Evid Synth"},{"issue":"10","key":"2441_CR19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119\u201326.","journal-title":"JBI Evid Synth"},{"key":"2441_CR20","volume-title":"In., EndNote 20 edn","author":"The EndNote Team","year":"2013","unstructured":"The EndNote Team. EndNote. In., EndNote 20 edn. Philadelphia, PA: Clarivate; 2013."},{"doi-asserted-by":"crossref","unstructured":"Ouzzani Mourad and Hammady HaF. Zbys and Elmagarmid, Ahmed: Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 2016.","key":"2441_CR21","DOI":"10.1186\/s13643-016-0384-4"},{"issue":"7","key":"2441_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"10","key":"2441_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/09540121003692185","volume":"22","author":"N Abrahams","year":"2010","unstructured":"Abrahams N, Jewkes R, Lombard C, Mathews S, Campbell J, Meel B. Impact of telephonic psycho-social support on adherence to post-exposure prophylaxis (PEP) after rape. AIDS Care. 2010;22(10):1173\u201381.","journal-title":"AIDS Care"},{"issue":"5","key":"2441_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"22","key":"2441_CR25","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, et al. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"issue":"6","key":"2441_CR26","doi-asserted-by":"publisher","first-page":"e1003670","DOI":"10.1371\/journal.pmed.1003670","volume":"18","author":"C Celum","year":"2021","unstructured":"Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, Pathak S, Mgodi N, Bekker LG, Donnell DJ, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18(6):e1003670.","journal-title":"PLoS Med"},{"issue":"2","key":"2441_CR27","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1016\/S2352-3018(19)30337-6","volume":"7","author":"MH Chung","year":"2020","unstructured":"Chung MH, McGrath CJ, Beck IA, Levine M, Milne RS, So I, Andersen N, Dross S, Coombs RW, Chohan B, et al. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial. lancet HIV. 2020;7(2):e104\u201312.","journal-title":"lancet HIV"},{"issue":"9812","key":"2441_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(11)61653-X","volume":"379","author":"HM Coovadia","year":"2012","unstructured":"Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chib aL, Chetty V, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet (London England). 2012;379(9812):221\u20138.","journal-title":"Lancet (London England)"},{"issue":"9155","key":"2441_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(98)11046-2","volume":"353","author":"F Dabis","year":"1999","unstructured":"Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, Leroy V, Simonon A, Cartoux M, Combe P, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in C\u00f4te d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission M\u00e8re-Enfant. Lancet (London England). 1999;353(9155):786\u201392.","journal-title":"Lancet (London England)"},{"issue":"4","key":"2441_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/sti.2010.047142","volume":"87","author":"G de Bruyn","year":"2011","unstructured":"de Bruyn G, Shiboski S, van der Straten A, Blanchard K, Chipato T, Ramjee G, Montgomery E, Padian N. The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect. 2011;87(4):301\u20135.","journal-title":"Sex Transm Infect"},{"issue":"11","key":"2441_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S1473-3099(18)30428-6","volume":"18","author":"S Delany-Moretlwe","year":"2018","unstructured":"Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, et al. Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018;18(11):1241\u201350.","journal-title":"Lancet Infect Dis"},{"issue":"10195","key":"2441_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","volume":"394","author":"HIV incidence among","year":"2019","unstructured":"HIV incidence among. women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet (London England). 2019;394(10195):303\u201313.","journal-title":"Lancet (London England)"},{"issue":"11","key":"2441_CR33","doi-asserted-by":"publisher","first-page":"e3784","DOI":"10.1371\/journal.pone.0003784","volume":"3","author":"V Halpern","year":"2008","unstructured":"Halpern V, Ogunsola F, Obunge O, Wang CH, Onyejepu N, Oduyebo O, Taylor D, McNeil L, Mehta N, Umo-Otong J, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS ONE. 2008;3(11):e3784.","journal-title":"PLoS ONE"},{"doi-asserted-by":"publisher","unstructured":"Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (New York, NY). 2010;329(5996):1168\u201374. https:\/\/doi.org\/10.1126\/science.1193748.","key":"2441_CR34","DOI":"10.1126\/science.1193748"},{"issue":"6","key":"2441_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"8","key":"2441_CR36","doi-asserted-by":"publisher","first-page":"e1003226","DOI":"10.1371\/journal.pmed.1003226","volume":"17","author":"M Maskew","year":"2020","unstructured":"Maskew M, Brennan AT, Fox MP, Vezi L, Venter WDF, Ehrenkranz P, Rosen S. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial. PLoS Med. 2020;17(8):e1003226.","journal-title":"PLoS Med"},{"issue":"7","key":"2441_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/OLQ.0b013e3181cfcc4b","volume":"37","author":"SN Mavedzenge","year":"2010","unstructured":"Mavedzenge SN, Pol BV, Cheng H, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, Straten A. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis. 2010;37(7):460\u20136.","journal-title":"Sex Transm Dis"},{"issue":"9749","key":"2441_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","volume":"376","author":"S McCormack","year":"2010","unstructured":"McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (London England). 2010;376(9749):1329\u201337.","journal-title":"Lancet (London England)"},{"issue":"11","key":"2441_CR39","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s10461-016-1312-2","volume":"20","author":"BS Mensch","year":"2016","unstructured":"Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS Behav. 2016;20(11):2654\u201361.","journal-title":"AIDS Behav"},{"doi-asserted-by":"crossref","unstructured":"Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.\u00a0J\u00a0Infect\u00a0Dis. 2003;187(5):725\u201335.","key":"2441_CR40","DOI":"10.1086\/367898"},{"issue":"4","key":"2441_CR41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/jama.2014.8735","volume":"312","author":"NR Mugo","year":"2014","unstructured":"Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, et al. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial. JAMA. 2014;312(4):362\u201371.","journal-title":"JAMA"},{"issue":"2","key":"2441_CR42","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S2352-3018(20)30300-3","volume":"8","author":"A Nel","year":"2021","unstructured":"Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A, Steytler J, van der Ryst E, Craig C, Louw C, et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. lancet HIV. 2021;8(2):e77\u201386.","journal-title":"lancet HIV"},{"issue":"3","key":"2441_CR43","doi-asserted-by":"publisher","first-page":"e0147743","DOI":"10.1371\/journal.pone.0147743","volume":"11","author":"A Nel","year":"2016","unstructured":"Nel A, Bekker LG, Bukusi E, Hellstr\u04e7m E, Kotze P, Louw C, Martinson F, Masenga G, Montgomery E, Ndaba N, et al. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa. PLoS ONE. 2016;11(3):e0147743.","journal-title":"PLoS ONE"},{"issue":"22","key":"2441_CR44","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, Kamali A, Kotze P, Louw C, Mabude Z, et al. Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. N Engl J Med. 2016;375(22):2133\u201343.","journal-title":"N Engl J Med"},{"issue":"9","key":"2441_CR45","doi-asserted-by":"publisher","first-page":"e43832","DOI":"10.1371\/journal.pone.0043832","volume":"7","author":"TA Odeny","year":"2012","unstructured":"Odeny TA, Bailey RC, Bukusi EA, Simoni JM, Tapia KA, Yuhas K, Holmes KK, McClell RS. Text messaging to improve attendance at post-operative clinic visits after adult male circumcision for HIV prevention: a randomized controlled trial. PLoS ONE. 2012;7(9):e43832.","journal-title":"PLoS ONE"},{"issue":"9","key":"2441_CR46","doi-asserted-by":"publisher","first-page":"e1002912","DOI":"10.1371\/journal.pmed.1002912","volume":"16","author":"S Rosen","year":"2019","unstructured":"Rosen S, Maskew M, Larson BA, Brennan AT, Tsikhutsu I, Fox MP, Vezi L, Bii M, Venter WDF. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya. PLoS Med. 2019;16(9):e1002912.","journal-title":"PLoS Med"},{"issue":"9","key":"2441_CR47","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.aids.0000232236.26630.35","volume":"20","author":"RL Shapiro","year":"2006","unstructured":"Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, et al. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS. 2006;20(9):1281\u20138.","journal-title":"AIDS"},{"issue":"9654","key":"2441_CR48","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","volume":"372","author":"S Skoler-Karpoff","year":"2008","unstructured":"Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedl B, Govender S, De Kock A, Cassim N, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet (London England). 2008;372(9654):1977\u201387.","journal-title":"Lancet (London England)"},{"issue":"2","key":"2441_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jama.292.2.202","volume":"292","author":"TE Taha","year":"2004","unstructured":"Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292(2):202\u20139.","journal-title":"JAMA"},{"issue":"3","key":"2441_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1473-3099(10)70288-7","volume":"11","author":"G Kesho Bora Study","year":"2011","unstructured":"Kesho Bora Study G, de Vincenzi I. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis. 2011;11(3):171\u201380.","journal-title":"Lancet Infect Dis"},{"issue":"9313","key":"2441_CR51","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(02)08214-4","volume":"359","author":"Efficacy of three short","year":"2002","unstructured":"Efficacy of three short-. course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet (London England). 2002;359(9313):1178\u201386.","journal-title":"Lancet (London England)"},{"issue":"7","key":"2441_CR52","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/jama.296.7.794","volume":"296","author":"I Thior","year":"2006","unstructured":"Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006;296(7):794\u2013805.","journal-title":"JAMA"},{"issue":"5","key":"2441_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, et al. Preexposure Prophylaxis for HIV Infection among African Women. N Engl J Med. 2012;367(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"9","key":"2441_CR54","doi-asserted-by":"publisher","first-page":"e1002895","DOI":"10.1371\/journal.pmed.1002895","volume":"16","author":"C Waitt","year":"2019","unstructured":"Waitt C, Orrell C, Walimbwa S, Singh Y, Kintu K, Simmons B, Kaboggoza J, Sihlangu M, Coombs JA, Malaba T, et al. Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study). PLoS Med. 2019;16(9):e1002895.","journal-title":"PLoS Med"},{"issue":"17","key":"2441_CR55","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/sim.4250","volume":"30","author":"ID Ha","year":"2011","unstructured":"Ha ID, Sylvester R, Legrand C, Mackenzie G. Frailty modelling for survival data from multi-centre clinical trials. Stat Med. 2011;30(17):2144\u201359.","journal-title":"Stat Med"},{"unstructured":"David GK, Mitchel K. Survival Analysis A Self-Learning Text. New York NY: Springer New York; 2005.","key":"2441_CR56"},{"issue":"5","key":"2441_CR57","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1089\/aid.2014.0241","volume":"31","author":"MJ Giganti","year":"2015","unstructured":"Giganti MJ, Luz PM, Caro-Vega Y, Cesar C, Padgett D, Koenig S, Echevarria J, McGowan CC, Shepherd BE. A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean. AIDS Res Hum Retroviruses. 2015;31(5):496\u2013503.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"32","key":"2441_CR58","doi-asserted-by":"publisher","first-page":"10601","DOI":"10.1523\/JNEUROSCI.0362-10.2010","volume":"30","author":"G Sally","year":"2010","unstructured":"Sally G, James AD, Bryce V. A Study of Clustered Data and Approaches to Its Analysis. J Neurosci. 2010;30(32):10601.","journal-title":"J Neurosci"},{"issue":"12","key":"2441_CR59","doi-asserted-by":"publisher","first-page":"e28759","DOI":"10.1371\/journal.pone.0028759","volume":"6","author":"B Zani","year":"2011","unstructured":"Zani B, Pienaar ED, Oliver J, Siegfried N. Randomized controlled trials of HIV\/AIDS prevention and treatment in Africa: results from the Cochrane HIV\/AIDS Specialized Register. PLoS ONE. 2011;6(12):e28759.","journal-title":"PLoS ONE"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-024-02441-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-024-02441-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-024-02441-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:02:35Z","timestamp":1736312555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-024-02441-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2441"],"URL":"https:\/\/doi.org\/10.1186\/s12874-024-02441-w","relation":{},"ISSN":["1471-2288"],"issn-type":[{"type":"electronic","value":"1471-2288"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}